UNSPSC 51441578: Indocyanine green

Indocyanine Green for Injection USP is a sterile, lyophilized green powder containing 25 mg of Indocyanine Green with no more than 5% sodium iodide. It is packaged with Sterile Water for Injection, USP used to dissolve the Indocyanine Green. Indocyanine Green for Injection USP is to be administered intravenously. Indocyanine Green for Injection USP is indicated for Determining Cardiac Output, Hepatic Function and Liver Blood Flow and for ophthalmic angiography.

UNSPSC 51441578 Indocyanine green is a Commodity code that in practice covers a much broader set of pharmaceutical and clinical diagnostic products than the nominal code name suggests. Recent state and local solicitations show procurement activity spanning naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, biotech research reagents, clinical diagnostics supplies, and laboratory equipment — all products ordered routinely by state agencies, county health departments, and university health systems through e-procurement catalogs and competitive bidding. The issuing bodies include county government health departments, state cooperative purchasing alliances serving multiple state and local jurisdictions, and academic health science centers. Purchases are typically structured as fixed-fee contracts with unit or MSRP-discount pricing models, quarterly or routine automated ordering through punchout catalogs, and multi-year terms with optional renewals.

Recent activity appears concentrated in Florida, Minnesota, and Texas. Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building. The University of Texas Health Science Center at San Antonio issued RFP 745-26-P19 (due June 4, 2026) for a Biotech Research, Clinical Diagnostics, and Equipment Catalog covering approximately 8,768 line items ordered in the prior contract year, requiring Jaggaer e-procurement punchout integration and HUB subcontracting plan compliance. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson wholesalers to participating state and local facilities including Oregon, with product availability required by May 15, 2026 and contract effectiveness July 1, 2026.